Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction

NCT06161818 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Adenocarcinoma of the Esophagus

Interventions

DRUG: FLOT-CROSS or CROSS-FLOT

Sponsor

Erasmus Medical Center